조영제 주입기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Contrast Media Injectors Market Summary

The global contrast media injectors market size was estimated at USD 2.24 billion in 2025 and is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 9.52% from 2026 to 2033. The market is experiencing significant growth driven by the rising volume of CT, MRI, and interventional radiology procedures that require precise and consistent contrast delivery.

Growing incidences of chronic diseases and an ageing population further increase the need for advanced imaging, boosting injector adoption. In addition, technological innovations such as automated injectors, dose-tracking software, and syringeless systems enhance workflow efficiency and patient safety, encouraging hospitals to upgrade.

According to the data published by the CDC in February 2024, among 129 million adults in the U.S., roughly 52% live with at least one major chronic disease. Additionally, around 27% of adults, or approximately 68 million people, suffer from multiple chronic conditions, with higher rates observed among older adults and women.

The growing demand for advanced diagnostic imaging is a key driver of the contrast media injectors market. As the use of CT, MRI, ultrasound, and angiography procedures increases, healthcare providers require precise and efficient delivery of contrast agents to ensure high-quality imaging results. Rising cases of chronic diseases such as cancer, cardiovascular, and neurological disorders further contribute to the need for accurate diagnostic visualization. This growing reliance on advanced imaging technologies is accelerating the adoption of automated and high-performance contrast media injectors, which enhance diagnostic accuracy, workflow efficiency, and patient safety.

According to ScienceDirect, CT and ultrasound demonstrated gradual growth in their respective shares, with CT rising from 4.0% to 4.4% and ultrasound from 11.8% to 12.4%, while MRI usage remained relatively stable, increasing slightly from 5.3% to 5.4% from 2020 to 2023. The graph below shows the increasing trend of advanced imaging, reflecting the growing adoption of high-end diagnostic modalities in clinical practice.

Global Contrast Media Injectors Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global contrast media injectors market report on the basis of product, type, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Injector Systems
  • CT injector systems
  • MRI injector systems
  • Cardiovascular/angiography injector systems
• Consumables
  • Tubing
  • Syringe
  • Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Single Head Injectors
• Dual-Head Injectors
• Syringeless Injectors
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Radiology
• Interventional Cardiology
• Interventional Radiology
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Type
  • 1.1.3. Application
  • 1.1.4. End-use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Contrast Media Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Imaging Tests
    • 3.2.1.2. Increasing Burden of Chronic Diseases
    • 3.2.1.3. Advancements in Technology
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Potential Complications and Risks Associated with Contrast Media Injections
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expanding Healthcare Infrastructure in Emerging Markets
    • 3.2.3.2. Increasing Research Activities
    • 3.2.3.3. Growing Adoption of Syringeless Products
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Shortage of Radiologists and Healthcare Professionals
• 3.3. Contrast Media Injectors Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining Power of Suppliers
    • 3.3.1.2. Bargaining Power of Buyers
    • 3.3.1.3. Threat of Substitutes
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape

Chapter 4. Contrast Media Injectors Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Contrast Media Injectors Market Product Movement Analysis
• 4.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Injector Systems
  • 4.4.1. Injector systems market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.2. CT injector systems
    • 4.4.2.1. CT injector systems market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.3. MRI injector systems
    • 4.4.3.1. MRI injector systems market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.4. Cardiovascular/angiography injector systems
    • 4.4.4.1. Cardiovascular/angiography injector systems market estimates and forecast 2021 to 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.2. Tubing
    • 4.5.2.1. Tubing market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.3. Syringe
    • 4.5.3.1. Syringe market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Contrast Media Injectors Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Contrast Media Injectors Market Type Movement Analysis
• 5.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Single Head Injectors
  • 5.4.1. Single head injectors market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Dual-Head Injectors
  • 5.5.1. Dual-head injectors market estimates and forecast 2021 to 2033 (USD Million)
• 5.6. Syringeless Injectors
  • 5.6.1. Syringeless injectors market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Contrast Media Injectors Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Contrast Media Injectors Market Type Movement Analysis
• 6.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 6.4. Radiology
  • 6.4.1. Radiology injectors market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Interventional Cardiology
  • 6.5.1. Interventional cardiology market estimates and forecast 2021 to 2033 (USD Million)
• 6.6. Interventional Radiology
  • 6.6.1. Interventional radiology market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Contrast Media Injectors: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Contrast Media Injectors Market End-Use Movement Analysis
• 7.3. Global Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
• 7.5. Diagnostic Centers
  • 7.5.1. Operating rooms market estimates and forecast 2021 to 2033 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory surgery centers market estimates and forecast 2021 to 2033 (USD Million)

Chapter 8. Contrast Media Injectors Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. Reimbursement scenario
    • 8.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 8.4.6. Denmark
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 8.4.8. Norway
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement scenario
    • 8.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 8.5.2. India
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 8.5.3. China
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 8.5.4. South Korea
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 8.5.5. Australia
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement scenario
    • 8.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement scenario
    • 8.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Bayer
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Bracco Group
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Ulrich Medical
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Guerbet Group
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Shenzhen Boon Medical Supply Co., Ltd
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. B.Braun SE
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Shenzhen Antmed Co., Ltd.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Ecomed Solutions
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
• 9.3. Heat Map Analysis/ Company Market Position Analysis
• 9.4. Estimated Company Market Share Analysis, 2025
• 9.5. List of Other Key Market Players